Rethinking the pharmaceutical marketing model
04 Feb 2005 | by John Singer
Should pharmaceutical companies re-evaluate their consumer marketing strategies?
Click
to remove filters
Despite extensive research on branding and brand equity in recent years, relatively little has been published on brand equity measurement. Dr. R.K. Srivastava, Emeritus Professor at Bombay University, discusses this key managerial issue.
Should pharmaceutical companies re-evaluate their consumer marketing strategies?